Related references
Note: Only part of the references are listed.Associations between structural and functional changes to the kidney in diabetic humans and mice
David W. Powell et al.
LIFE SCIENCES (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy
Maria Jose Soler et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes Subgroup Analyses From the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)
Josep Redon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice
Huifang Cheng et al.
KIDNEY INTERNATIONAL (2012)
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice
Chao-Sheng Lo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Mouse models of diabetic nephropathy
Charles E. Alpers et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Mouse Models of Diabetic Nephropathy
Frank C. Brosius et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Podocyte loss in aging OVE26 diabetic mice
Jennifer M. Teiken et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2008)
Dual effects of RAS blockade on blood pressure and podocyte function
Jocben Reiser et al.
CURRENT HYPERTENSION REPORTS (2007)
Rodent models of streptozotocin-induced diabetic nephropathy
Greg H. Tesch et al.
NEPHROLOGY (2007)
Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice
Yukiko Kanetsuna et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice
M.-L. Brezniceanu et al.
KIDNEY INTERNATIONAL (2007)
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice
Hui John Zhao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease
A Remuzzi et al.
KIDNEY INTERNATIONAL (2006)
Incidence of end-stage renal disease in patients with type 1 diabetes
P Finne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase
RM Touyz et al.
HYPERTENSION (2005)
Mouse models of diabetic nephropathy
MD Breyer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
KMI Caron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance
ZH Qi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Development of late-stage diabetic nephropathy in OVE26 diabetic mice
SR Zheng et al.
DIABETES (2004)
Activation of a local tissue angiotensin system in podocytes by mechanical strain
RV Durvasula et al.
KIDNEY INTERNATIONAL (2004)
A genetically clamped renin transgene for the induction of hypertension
KMI Caron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Diabetes, hypertension, and cardiovascular disease - An update
JR Sowers et al.
HYPERTENSION (2001)
Share Paper
